3-Hydroxypiperidine → N-(3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetraenoyl)-3-hydroxypiperidine
반응식
[CH3:1][C:2]([CH2:7][CH2:8][CH:9]=[C:10]([CH3:22])[CH2:11][CH2:12][CH:13]=[C:14]([CH3:21])[CH2:15][CH2:16][CH:17]=[C:18]([CH3:20])[CH3:19])=[CH:3][C:4]([OH:6])=O.[OH:23][CH:24]1[CH2:29][CH2:28][CH2:27][NH:26][CH2:25]1>>[CH3:1][C:2]([CH2:7][CH2:8][CH:9]=[C:10]([CH3:22])[CH2:11][CH2:12][CH:13]=[C:14]([CH3:21])[CH2:15][CH2:16][CH:17]=[C:18]([CH3:20])[CH3:19])=[CH:3][C:4]([N:26]1[CH2:27][CH2:28][CH2:29][CH:24]([OH:23])[CH2:25]1)=[O:6]참가 물질
3
실험 절차
The procedure of Example 1 was repeated except that 6.1 g of 3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenoic acid and 3.0 g of 3-hydroxypiperidine were used as starting materials. 7.4 g (yield 96%) of the title compound was obtained as a colorless oil.
출처 및 근거
- ORD 기록
- ord-82ff259194224e6ea0fbdfcd4bfde58e
- 출처 데이터셋
- uspto-grants-1988_08